Altman Advisors, Inc. Pfizer Inc Transaction History

Altman Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $642,279 - $737,541	24,808 Added 142.77%	42,184 $1.17 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $513,297 - $666,717	-19,644 Reduced 53.06%	17,376 $500,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $117,834 - $137,736	3,672 Added 11.01%	37,020 $1.23 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $217,511 - $283,168	5,522 Added 19.84%	33,348 $1.36 Million
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $81,663 - $106,602	-1,956 Reduced 6.57%	27,826 $1.43 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $37,546 - $45,834	-858 Reduced 2.8%	29,782 $1.3 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $23,078 - $27,364	496 Added 1.65%	30,640 $1.52 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $11,849 - $14,682	-259 Reduced 0.85%	30,144 $1.56 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $1.26 Million - $1.86 Million	30,403 New	30,403 $1.61 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Altman Advisors, Inc. with notifications on news.